Dermatomyositis occurring during of a with melanoma [2]

Melanoma Research

Volumn 14, Issue 5, 2004, Pages 435-436

  Michot, Carine ^a   Dereure, Olivier ^a,c   Baurain, Jean François ^b   Brichard, Vincent ^b,d   Guillot, Bernard ^a  

^a MONTPELLIER UNIVERSITY HOSPITAL   (France)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^c HÔPITAL SAINT ELOI   (France)

^d GSK   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER ANTIBODY; DACARBAZINE; MELAN A; METHOTREXATE; MONOPHENOL MONOOXYGENASE; PREDNISONE;

ADULT; ANAMNESIS; CASE REPORT; DERMATOMYOSITIS; DISEASE COURSE; DRUG TOLERABILITY; ERYTHEMA; HUMAN; LABORATORY TEST; LETTER; LUNG METASTASIS; MALE; MEDICAL EXAMINATION; MELANOMA; MUSCLE WEAKNESS; MYALGIA; PRIORITY JOURNAL; SKIN DISEASE; SKIN METASTASIS; TELANGIECTASIA; VACCINATION; ARTICLE; MIDDLE AGED; PATHOLOGY; SKIN TUMOR;

DERMATOMYOSITIS; HUMANS; MALE; MELANOMA; MIDDLE AGED; SKIN NEOPLASMS;

EID: 16644371221     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-200410000-00018     Document Type: Letter

References (9)

1. Maoz CR, Langevitz P, Livneh Sadeh M, Bank I, Gur H, Ehrenfeld M. High incidence of malignancies in patients with dermatomyositis and polymyositis: an 11-year analysis. Semin Arthritis Rheum 1998; 27:319-324.
2. Sunnenberg TD, Kitchens CS. Dermatomyositis associated with malignant melanoma. Parallel occurrence, remission, and relapse of the two processes in a patient. Cancer 1983; 51:2157-2158.
3. Scerri L, Zaki I, Allen BR, Golding P. Dermatomyositis associated with malignant melanoma-case report and review of the literature. Clin Exp Dermatol 1994; 19:523-525.
4. Sais G, Marcoval J, Juggla A, Curco N, Servitje O. Dermatomyositis and metastatic malignant melanoma, with complete regression of the primary lesion. Br J Dermatol 1995; 133:1012.
5. Shorr AF, Yacavone M, Seguin S, Jackson LW, Dennis GJA, Blumstein Z. Dermatomyositis and malignant melanoma. Am J Med Sci 1997; 313:249-251.
6. Dietrich LL, Bridges AJ, Albertini MR. Dermatomyositis after interferon alpha treatment. Med Oncol 2000; 17:64-69.
7. Quèreux G, Lachaise S, Khammari A, Drèno B. Dermatomyosite associée à l'interféron aα chez une patient suivie pour mélanome. Ann Dermatol Venereol 2001; 128:S203-S204.
8. Gilboa E. The risk of autoimmunity associated with tumor immunotherapy. Nat Immunol 2001; 2:789-792.
9. Overwijk WW, Lee DS, Surman DR, Irvine KR, Touloukian CE, Chan CC, et al. Vaccination with a recombinant vaccinia virus encoding a 'self' antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytes. Proc Natl Acad Sci USA 1999; 96:2982-2987.